NF-κB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II

Molecular Cell

Volumn 8, Issue 2, 2001, Pages 327-337

  Barboric, Matjaz ^a,c   Nissen, Robert M ^b   Kanazawa, Satoshi ^a   Jabrane Ferrat, Nabila ^a   Peterlin, B Matija ^a,d  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

^d 415 502 1901 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; ELONGATION FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; PROTEIN; RNA POLYMERASE II; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; HYBRID PROTEIN; NUCLEIC ACID SYNTHESIS INHIBITOR; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; KIDNEY CELL; NONHUMAN; PROTEIN BINDING; SENSITIZATION; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS GENE; CELL CULTURE; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHYSIOLOGY; REPORTER GENE;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

APOPTOSIS; DICHLORORIBOFURANOSYLBENZIMIDAZOLE; DNA-BINDING PROTEINS; GENE PRODUCTS, TAT; GENES, REPORTER; HIV-1; HUMANS; INTERLEUKIN-8; NF-KAPPA B; NUCLEIC ACID SYNTHESIS INHIBITORS; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT FUSION PROTEINS; RNA POLYMERASE II; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034741714     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(01)00314-8     Document Type: Article

References (34)

1. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts
2. Control of apoptosis by Rel/NF-κB transcription factors
3. A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells
4. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription
5. Flavopiridol inhibits P-TEFb and blocks HIV-1 replication
6. Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II
7. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat
8. The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat
9. Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T
10. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA
11. Synergism between Tat and VP16 in trans-activation of HIV-1 LTR
12. Transcription factor TFIIH is required for promoter melting in vivo
13. TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes
14. Class II transactivator: Mastering the art of major histocompatibility complex expression
15. Control of RNA initiation and elongation at the HIV-1 promoter
16. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection
17. Phosphorylation meets ubiquitination: The control of NF-κB activity
18. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB
19. Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription
20. P-TEFb kinase recruitment and function at heat shock loci
21. Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function
22. Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators
23. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase
24. Transcription factor IIE binds preferentially to RNA polymerase IIa and recruits TFIIH: A model for promoter clearance
25. The glucocorticoid receptor inhibits NFκB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain
26. Mapping chromosomal proteins in vivo by formaldehyde-crosslinked-chromatin immunoprecipitation
27. Transcriptional pausing at +62 of the HIV-1 nascent RNA modulates formation of the TAR RNA structure
28. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II
29. Transcriptional regulation of the Igκ gene by promoter-proximal pausing of RNA polymerase II
30. Tat transactivation: A model for the regulation of eukaryotic transcriptional elongation
31. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence
32. Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer
33. TIP30 has an intrinsic kinase activity required for up-regulation of a subset of apoptotic genes
34. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription